SCHEMBL30392961

SCHEMBL30392961

CCOC(=O)c1cnc2c(N(C)Cc3ccc(OC)cc3)cc(Nc3cccc(-c4ccc(C5OCCO5)cn4)c3)nn12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 3/20 0.37
▸ TYK2 P29597 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ EGFR P00533 1/20 0.33
▸ ERBB3 P21860 1/20 0.33
▸ AURKA O14965 3/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ IDO1 P14902 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ FYN P06241 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26100287 1.00 FAAH (0.37) FAAHTYK2PDE4DPOLBAPEX1
SCHEMBL26510925 0.92 TYK2 (0.37) TYK2PDE4DMAPTEGFRAURKA
SCHEMBL26099790 0.92 TYK2 (0.37) TYK2PDE4DMAPTEGFRAURKA
Potassium SCHEMBL30392578 0.92 TYK2 (0.37) TYK2PDE4DMAPTEGFRAURKA
Potassium Ion SCHEMBL30391293 0.91 TYK2 (0.35) TYK2PDE4DMAPTEGFRAURKA
Potassium Ion SCHEMBL26098159 0.91 TYK2 (0.35) TYK2PDE4DMAPTEGFRAURKA
SCHEMBL26100963 0.89 TYK2 (0.40) TYK2PDE4D
SCHEMBL30392554 0.89 FAAH (0.33) FAAHTYK2PDE4DPOLBAPEX1
SCHEMBL26100863 0.89 FAAH (0.33) FAAHTYK2PDE4DPOLBAPEX1
SCHEMBL26101565 0.88 TYK2 (0.39) FAAHTYK2PDE4DAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback